Clinical data collected | Blood samples |
Date of birth | FBC |
Age at time of assessment | Liver enzymes (albumin, bilirubin, ALT, ALP) |
Sex at birth | AST |
Ethnicity | GGT |
Weight | HbA1c |
Height | FIB-4 score |
BMI | Lipids |
Waist and Hip circumference | ELF |
Blood pressure | PRO-C3 |
AUDIT score33 | Blood for storage to assess future novel biomarkers of liver disease |
Current alcohol consumption (average units/week over last year) | |
History of previous heavy alcohol consumption (>35 U/week for females or >50 U/week for males) for >1 year | |
Smoking history | |
Relevant medical history including: hypertension, T2DM, dyslipidaemia, obstructive sleep apnoea | |
Current medications | |
EQ-5D-L questionnaire34 |
ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; AUDIT, Alcohol Use Disorders Identification Tool; ELF, enhanced liver fibrosis test; EQ-5D-L, EuroQol-5 Dimensions-Level; FBC, full blood count; GGT, gamma glutamyl transferase; T2DM, type 2 diabetes.